Phase 2a trial of GBS-01 for advanced pancreatic cancer refractory to gemcitabine and fluoropyrimidine chemotherapy.
Phase of Trial: Phase II
Latest Information Update: 06 Oct 2016
Price : $35 *
At a glance
- Drugs GBS 01 (Primary)
- Indications Pancreatic cancer
- Focus Therapeutic Use
- 03 Oct 2016 Status changed from active, no longer recruiting to completed.
- 05 Nov 2013 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan record.
- 15 Mar 2013 New trial record